Authors:
Austin, NE
Avenell, KY
Boyfield, I
Branch, CL
Hadley, MS
Jeffrey, P
Johnson, CN
Macdonald, GJ
Nash, DJ
Riley, GJ
Smith, AB
Stemp, G
Thewlis, KM
Vong, AKK
Wood, MD
Citation: Ne. Austin et al., Design and synthesis of novel 2,3-dihydro-1H-isoindoles with high affinityand selectivity for the dopamine D-3 receptor, BIOORG MED, 11(5), 2001, pp. 685-688
Authors:
Austin, NE
Avenell, KY
Boyfield, I
Branch, CL
Hadley, MS
Jeffrey, P
Johnson, CN
Macdonald, GJ
Nash, DJ
Riley, GJ
Smith, AB
Stemp, G
Thewlis, KM
Vong, AKK
Wood, M
Citation: Ne. Austin et al., Novel 2,3,4,5-tetrahydro-1H-3-benzazepines with high affinity and selectivity for the dopamine D-3 receptor, BIOORG MED, 10(22), 2000, pp. 2553-2555
Authors:
Bromidge, SM
Dabbs, S
Davies, S
Duckworth, DM
Forbes, IT
Jones, GE
Jones, J
King, FD
Saunders, DV
Blackburn, TP
Holland, V
Kennett, GA
Lightowler, S
Middlemiss, DN
Riley, GJ
Trail, B
Wood, MD
Citation: Sm. Bromidge et al., 1-[2-[(heteroaryloxy)heteroaryl]carbamoyl]indolines: Novel and selective 5-HT2C receptor inverse agonists with potential as antidepressant/anxiolyticagents, BIOORG MED, 10(16), 2000, pp. 1863-1866
Authors:
Bromidge, SM
Davies, S
Duckworth, DM
Forbes, IT
Jones, GE
Jones, J
King, FD
Blackburn, TP
Holland, V
Kennett, GA
Lightowler, S
Middlemiss, DN
Riley, GJ
Trail, B
Wood, MD
Citation: Sm. Bromidge et al., 1-[2-[(heteroarylmethoxy)aryl]carbamoyl]indolines are selective and orallyactive 5-HT2C receptor inverse agonists, BIOORG MED, 10(16), 2000, pp. 1867-1870
Authors:
Reavill, C
Taylor, SG
Wood, MD
Ashmeade, T
Austin, NE
Avenell, KY
Boyfield, I
Branch, CL
Cilia, J
Coldwell, MC
Hadley, MS
Hunter, AJ
Jeffrey, P
Jewitt, F
Johnson, CN
Jones, DNC
Medhurst, AD
Middlemiss, DN
Nash, DJ
Riley, GJ
Routledge, C
Stemp, G
Thewlis, KM
Trail, B
Vong, AKK
Hagan, JJ
Citation: C. Reavill et al., Pharmacological actions of a novel, high-affinity, and selective human dopamine D-3 receptor antagonist, SB-277011-A, J PHARM EXP, 294(3), 2000, pp. 1154-1165
Authors:
Stemp, G
Ashmeade, T
Branch, CL
Hadley, MS
Hunter, AJ
Johnson, CN
Nash, DJ
Thewlis, KM
Vong, AKK
Austin, NE
Jeffrey, P
Avenell, KY
Boyfield, I
Hagan, JJ
Middlemiss, DN
Reavill, C
Riley, GJ
Routledge, C
Wood, M
Citation: G. Stemp et al., Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A potent and selective dopamine D-3 receptor antagonist with high oral bioavailability and CNS penetration in the rat, J MED CHEM, 43(9), 2000, pp. 1878-1885
Authors:
Bromidge, SM
Dabbs, S
Davies, DT
Davies, S
Duckworth, DM
Forbes, IT
Gaster, LM
Ham, P
Jones, GE
King, FD
Mulholland, KR
Saunders, DV
Wyman, PA
Blaney, FE
Clarke, SE
Blackburn, TP
Holland, V
Kennett, GA
Lightowler, S
Middlemiss, DN
Trail, B
Riley, GJ
Wood, MD
Citation: Sm. Bromidge et al., Biarylcarbamoylindolines are novel and selective 5-HT2C receptor inverse agonists: Identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agent, J MED CHEM, 43(6), 2000, pp. 1123-1134
Authors:
Lovell, PJ
Bromidge, SM
Dabbs, S
Duckworth, DM
Forbes, IT
Jennings, AJ
King, FD
Middlemiss, DN
Rahman, SK
Saunders, DV
Collin, LL
Hagan, JJ
Riley, GJ
Thomas, DR
Citation: Pj. Lovell et al., A novel, potent, and selective 5-HT7 antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)-ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970), J MED CHEM, 43(3), 2000, pp. 342-345
Authors:
Wood, MD
Boyfield, I
Nash, DJ
Jewitt, FR
Avenell, KY
Riley, GJ
Citation: Md. Wood et al., Evidence for antagonist activity of the dopamine D3 receptor partial agonist, BP 897, at human dopamine D3 receptor, EUR J PHARM, 407(1-2), 2000, pp. 47-51
Authors:
Hagan, JJ
Price, GW
Jeffrey, P
Deeks, NJ
Stean, T
Piper, D
Smith, MI
Upton, N
Medhurst, AD
Middlemiss, DN
Riley, GJ
Lovell, PJ
Bromidge, SM
Thomas, DR
Citation: Jj. Hagan et al., Characterization of SB-269970-A, a selective 5-HT7 receptor antagonist, BR J PHARM, 130(3), 2000, pp. 539-548
Citation: Sb. Dimmitt et Gj. Riley, Selective serotonin receptor uptake inhibitors can reduce restless legs symptoms, ARCH IN MED, 160(5), 2000, pp. 712-712
Authors:
Bromidge, SM
Dabbs, S
Davies, DT
Davies, S
Duckworth, DM
Forbes, IT
Gadre, A
Ham, P
Jones, GE
King, FD
Saunders, DV
Thewlis, KM
Vyas, D
Blackburn, TP
Holland, V
Kennett, GA
Riley, GJ
Wood, MD
Citation: Sm. Bromidge et al., Model studies on a synthetically facile series of N-substituted phenyl-N '-pyridin-3-yl ureas leading to 1-(3-pyridylcarbamoyl) indolines that are potent and selective 5-HT2C/2B receptor antagonists, BIO MED CH, 7(12), 1999, pp. 2767-2773
Authors:
Austin, NE
Avenell, KY
Boyfield, I
Branch, CL
Coldwell, MC
Hadley, MS
Jeffrey, P
Johns, A
Johnson, CN
Nash, DJ
Riley, GJ
Smith, SA
Stacey, RC
Stemp, G
Thewlis, KM
Vong, AKK
Citation: Ne. Austin et al., Novel 1,2,3,4-tetrahydroisoquinolines with high affinity and selectivity for the dopamine D-3 receptor, BIOORG MED, 9(2), 1999, pp. 179-184
Authors:
Avenell, KY
Boyfield, I
Hadley, MS
Johnson, CN
Nash, DJ
Riley, GJ
Stemp, G
Citation: Ky. Avenell et al., Heterocyclic analogues of 2-aminotetralins with high affinity and selectivity for the dopamine D-3 receptor, BIOORG MED, 9(18), 1999, pp. 2715-2720
Citation: Gj. Riley et Kg. Gebremedhin, An empirical model for predicting the foundation modulus of wood for metal-plate connector teeth, T ASAE, 42(3), 1999, pp. 755-760
Citation: Gj. Riley et Kg. Gebremedhin, Axial and rotational stiffness model of metal-plate-connected wood truss joints, T ASAE, 42(3), 1999, pp. 761-770
Authors:
Watson, J
Brough, S
Coldwell, MC
Gager, T
Ho, M
Hunter, AJ
Jerman, J
Middlemiss, DN
Riley, GJ
Brown, AM
Citation: J. Watson et al., Functional effects of the muscarinic receptor agonist, xanomeline, at 5-HT1 and 5-HT2 receptors, BR J PHARM, 125(7), 1998, pp. 1413-1420